Frequently Asked Questions
The market is segmented based on , By Product (Instruments, Reagents and kits, Consumables), Application (Clinical Disease Diagnosis, Food and Beverage Testing, Pharmaceutical and Biological Drug Testing, Environmental Testing, Cosmetics and Personal Care Products Testing, Research Applications, Other Applications), Method (Growth-Based Rapid Microbiology Testing, Cellular Component-Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing, Viability-Based Rapid Microbiology Diagnostic Testing, Other Rapid Microbiology Testing Methods), End-User (Laboratories and Hospitals, Food and Beverage Companies, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Other End-Users) – Industry Trends and Forecast to 2030.
.
The Global Rapid Microbiology Testing Market size was valued at USD 4514.27 USD Million in 2022.
The Global Rapid Microbiology Testing Market is projected to grow at a CAGR of 9.4% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, BD, BioMerieux, Bruker, Charles River, Danaher, Don Whitley Scientific Limited, Merck KGaA, Neogen Corporation, Quidel Corporation, Rapid Micro Biosystems, Sartorius Group, Thermo Fisher Scientific, TSI, Vivione Biosciences , ERBA Diagnostics, Vedalab, Rtalabs, Shimadzu Corporation, Pall Corporation, Mocon, .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
